Gossamer Bio is a San Diego biopharmaceutical company developing seralutinib, an inhaled drug for pulmonary hypertension. It last closed at $10.72 on Nov 20, down 4.54% on the day. The next earnings report for GOSS is expected around Tue, Mar 16, 2027, after the close. For the quarter ended Sep 2026, GOSS reported EPS of -$7.36 on revenue of $38.4M, with revenue up 189.1% from a year ago. Over its last 8 reports the stock moved an average of 10.1% the session after earnings.
AI Auto Pilots
Is GOSS in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold GOSS.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on GOSSStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
GOSS · as of the Nov 20 close · updated each morning
Bounce inside a longer downtrend
The stock is 2% above its 20 day and 3% above its 50 day average. It is 148% below its 200 day average, so the longer trend is down. Momentum is improving (RSI 51). The nearest support is the swing low (Jul 24) at $10.57, and the nearest resistance the Pivot at $10.99.
Short trendBullish
Long trendBearish
MomentumImproving
StretchNormal
VolatilityNormal, 9.7%/day
Key levels
$309.6052 week high+2788.1%
$26.58200 day average+147.9%
$11.92100 day average+11.2%
$11.33Pivot R1+5.7%
$11.08Swing high (Oct 29)+3.4%
$10.99Pivot+2.5%
$10.72Last close
$10.57Swing low (Jul 24)−1.4%
$10.4920 day average−2.1%
$10.4050 day average−3.0%
$10.38Pivot S1−3.2%
$8.2952 week low−22.7%
Indicators
RSI (14)
51.16
Middle of its range
Neutral
MACD
0.24
Above its signal line
Bullish
Stochastic
69.5
Middle of its range
Neutral
ADX (14)
8.7
No clear trend
Williams %R
-42.7
Oversold below −80, overbought above −20
Neutral
CCI (20)
55.9
Oversold below −100, overbought above 100
Neutral
Rate of change
+9.7%
Change over 10 sessions
Bullish
ATR (14)
$1.04
Typical daily range, 9.7% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Below
MA 200Below
Downtrend, nearing oversold
Short trendBearish
Long trendBearish
MomentumFading
StretchNear oversold
VolatilityNormal, 51.7%/day
Key levels
$309.6052 week high+2788.1%
$26.58200 day average+147.9%
$11.92100 day average+11.2%
$11.33Pivot R1+5.7%
$11.08Swing high (Oct 29)+3.4%
$10.99Pivot+2.5%
$10.72Last close
$10.57Swing low (Jul 24)−1.4%
$10.4920 day average−2.1%
$10.4050 day average−3.0%
$10.38Pivot S1−3.2%
$8.2952 week low−22.7%
Indicators
RSI (14)
31.40
Weak, oversold below 30
Neutral
MACD
-11.05
Above its signal line
Bullish
Stochastic
24.9
Middle of its range
Neutral
ADX (14)
33.4
Trending down
Williams %R
-72.4
Oversold below −80, overbought above −20
Neutral
CCI (20)
-38.8
Oversold below −100, overbought above 100
Neutral
Rate of change
−0.1%
Change over 10 sessions
Bearish
ATR (14)
$5.54
Typical daily range, 51.7% of price
MA 10Above
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for GOSS
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how GOSS did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow GOSS usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for GOSSHow many large options trades hit GOSS, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in GOSS in the last 90 days.
From SEC Form 4 filings by GOSS's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether GOSS is in one of them and how their past GOSS trades turned out.
Gossamer Bio is a biopharmaceutical company based in San Diego, California. It is developing seralutinib, an investigational inhaled medicine for pulmonary arterial hypertension and for pulmonary hypertension linked to interstitial lung disease. The drug is still in clinical trials and is not yet approved for sale. The company works with Chiesi on development and potential commercialization, and it focuses on people living with pulmonary hypertension.